Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.00098 | 1 |
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.00066 | 1 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.00011 | 1 |